SCHEMBL2627577

SCHEMBL2627577

c1ccc(-n2c3cc(-c4ccc(N(c5ccc(-c6ccncc6)cc5)c5ccc(-c6ccncc6)cc5)cc4)ccc3c3c4ccccc4c4ccc5ccccc5c4c32)cc1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 2/20 0.37
▸ MEN1 O00255 1/20 0.37
▸ HSP90AA1 P07900 1/20 0.37
▸ KMT2A Q03164 1/20 0.37
▸ HTR6 P50406 5/20 0.37
▸ ALDH1A1 P00352 2/20 0.37
▸ KDM4E B2RXH2 2/20 0.37
▸ HPGD P15428 1/20 0.37
▸ KHK P50053 1/20 0.33
▸ MAPK10 P53779 5/20 0.33
▸ MAPK9 P45984 4/20 0.33
▸ SMN1; SMN2 Q16637 1/20 0.32
▸ CYP1A1 P04798 1/20 0.32
▸ CYP1A2 P05177 1/20 0.32
▸ POLB P06746 1/20 0.32
▸ CFTR P13569 1/20 0.32
▸ CYP1B1 Q16678 1/20 0.32
▸ CHEK1 O14757 1/20 0.32
▸ MAPK8 P45983 2/20 0.32
▸ IMPDH2 P12268 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2627569 0.98 MAPT (0.37) MAPTMEN1HSP90AA1KMT2AHTR6
SCHEMBL2627558 0.91 MAPT (0.36) MAPTMEN1HSP90AA1KMT2AHTR6
SCHEMBL2627551 0.85 KDM4E (0.33) MAPTALDH1A1KDM4EHPGD
SCHEMBL2627582 0.84 MAPT (0.42) MAPTMEN1HSP90AA1KMT2AHTR6
SCHEMBL2627556 0.84 MAPT (0.39) MAPTMEN1HSP90AA1KMT2AHTR6
SCHEMBL17412225 0.83 KDM4E (0.33) MAPTMEN1HSP90AA1KMT2AALDH1A1
SCHEMBL2627526 0.83 DYRK1A (0.35) MAPTMEN1HSP90AA1KMT2AHTR6
SCHEMBL23741509 0.82 L3MBTL1 (0.34) MAPTMEN1KMT2AALDH1A1KDM4E
SCHEMBL19152251 0.79 KDM4E (0.36) MAPTMEN1HSP90AA1KMT2AHTR6
SCHEMBL21450247 0.79 KDM4E (0.36) MAPTMEN1HSP90AA1KMT2AHTR6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9362506-B2 Heterocyclic compound and organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2016-06-07 — — US disclosed
US-9362506-B2 Heterocyclic compound and organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2016-06-07 — — US disclosed
US-20140291654-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO LTD (KR) 2014-10-02 — — US disclosed
US-20140291654-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO LTD (KR) 2014-10-02 — — US disclosed
US-8815417-B2 Heterocyclic compound and organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2014-08-26 — — US disclosed
US-8815417-B2 Heterocyclic compound and organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2014-08-26 — — US disclosed
US-20120097929-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG MOBILE DISPLAY CO., LTD. (KR) 2012-04-26 — — US disclosed
US-20120097929-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG MOBILE DISPLAY CO., LTD. (KR) 2012-04-26 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120097929-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY2, CRY1, CCNE2 MAPT 2004/4885MEN1 298/4885HSP90AA1 4448/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback